Investor Alert

New York Markets After Hours

Sept. 16, 2019, 3:18 a.m. EDT

Natural Killer Cell Therapeutics Market and its Future Outlook During the Period of 2019 – 2024

Sep 16, 2019 (Hitech News Daily via COMTEX) -- Natural killer (NK) cell is a component of innate immunity system that targets cancer cells, and can be used as a therapeutic agent. NK cells target the cells losing MHC-I in cancer, a phenotype that is similar to certain cells in immune-privileged sites whose milieus are separated from peripheral blood.

The global natural killer cell therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% from 2019 to 2026.

Download Sample Copy @ https://www.bigmarketresearch.com/request-sample/3250664?utm_source=ANIL-HTN

Top Market Players: Affimed N.V., Celgene Corporation, Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics BV, Innate Pharma S.A., Nantkwest Inc., Nkarta Therapeutics, Inc., NKT Therapeutics Inc., Ziopharm Oncology Inc.

The growth of the global natural killer cell therapeutics market is driven by rise in use of NK cells to treat cancer, infections, and liver diseases. Moreover, NK cells play vital role in tumor immune-surveillance, which has significantly boosted their adoption across the globe. In addition, rise in awareness among the population regarding various immunotherapies and increase in R&D for the development of bi-specific antibody for engaging NK cells to eliminate tumor cells propel the global natural killer cell therapeutics market growth. However, lack of specificity and poor in-vivo survival of the cells limit the growth of the market. Furthermore, higher costs associated with the therapies and adverse side effects are expected to hamper the market growth in the coming years. Conversely, significant surge in R&D activities toward development of immunotherapy in developing economies is anticipated to offer lucrative opportunities for the market.

The global natural killer cell therapeutics market is segmented based on therapeutics, application, end user, and region. Depending on therapeutics, the natural killer cells therapeutics market is classified into NK cell therapies and NK cell directed antibodies. By application, it is categorized into cancer, gastrointestinal diseases, immunoproliferative disorders, and others. On the basis of end user, it is segregated into hospitals, research centers & institutes, and others. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.


  • This report entails a detailed quantitative analysis along with the current market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.

  • The global natural killer cell therapeutics market size and estimations are based on a comprehensive analysis of key developments.

  • A qualitative analysis based on innovative products facilitates strategic business planning.

  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Avail Discount on Report @ https://www.bigmarketresearch.com/request-for-discount/3250664?utm_source=ANIL-HTN

Table of Content


1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models


2.1. CXO perspective


3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Porter's five forces analysis

3.4. Top player positioning

3.5. Market dynamics

3.5.1. Drivers Rise in incidence of cancer across the globe Increase in government expenditure on healthcare Surge in awareness regarding immunotherapy

3.5.2. Restraints High cost of cancer immunotherapy treatment Stringent government regulations toward approval of immunotherapy

3.5.3. Opportunity Surge in R&D activities toward the development of immunotherapy

3.6. Government regulatory scenerio

3.6.1. U.S.

3.6.2. Europe

3.6.3. Japan

3.6.4. Thailand

3.6.5. Singapore

3.6.6. Malaysia

3.6.7. Mexico

3.6.8. Australia

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact us:Mr. Abhishek Paliwal5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Direct: +1-971-202-1575
Toll Free: +1-800-910-6452
E-mail: help@bigmarketresearch.com

The post Natural Killer Cell Therapeutics Market and its Future Outlook During the Period of 2019 – 2024 appeared first on Hitech News Daily. .


Link to MarketWatch's Slice.